Summary
The effect of polysaccharide peptide (PSP), an immunomodulator isolated fromCoriolus versicolor COV-1, on the disposition of paracetamol was investigated in the rat. PSP (100 and 200 mg/kg, i.v.) was administered 30 min before a moderate dose (100 mg/kg, i.v.) of paracetamol was given. Plasma and bile concentrations of paracetamol, paracetamol glucuronide and paracetamol sulphate were measured by high performance liquid chromatography. The pharmacokinetics of paracetamol (100 mg/kg) alone was consistent with those reported previously, using a one-compartment model. PSP (200 mg/kg) significantly (P<0.05) increased the clearance (controls, 19.06 ± 2.74 ml/min/kg: PSP treated, 26.22 ± 0.84 ml/min/kg) and volume of distribution (controls, 1.35 ± 0.11 l/kg: PSP treated, 1.61 ± 0.04 l/kg) of paracetamol by 37% and 21%, respectively. These changes were associated with concomitant increases in the glucuronide and sulphate metabolites in plasma, with significant increases in the Cmax and Tmax for both metabolites. The biliary excretion rate of paracetamol glucuronide and paracetamol sulphate were also measured. The Cmax values of paracetamol sulphate were significantly (P<0.01) increased by 2.4-fold from 907.8 ± 157.7 μg/ml (controls) to 3061 ± 331 μg/ml after PSP treatment. The lower dose of PSP (100 mg/kg) had no significant effect on the disposition of paracetamol in this study, which agreed with previous reports that a low dose of PSP (100–200 mg/kg, i.p.) was less effective in the protection against paracetamol-induced hepatotoxicity. The time course of the increase in paracetamol sulphate in plasma and bile in this study coincided with the transient perturbation of glutathione (GSH) turnover by a similar dose range of PSP previously described, such that more cysteine was available for oxidation to inorganic sulphate. This increase in sulphate conjugation by PSP would, in part, contribute to the increase in disposition of paracetamol and may be related to the ability of PSP to decrease the covalent binding of paracetamol to microsomal proteins previously reported. Further studies are necessary to understand the mechanism(s) involved in the PSP-induced increases in paracetamol glucuronide and paracetamol sulphate formation and biliary excretion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AUC:
-
area under curve
- CL:
-
clearance
- PSP:
-
polysaccharide peptide
- T1/2 :
-
half life
- Vd:
-
volume of distribution
References
Yang Q.Y., Jong S.C., Li X.Y., Zhou J.X., Chen Rt., Xu L.Z. (1991): Antitumour and immunomodulating activities of the polysaccharide peptide (PSP) ofCoriolus versicolor. J. Immunol. Immunopharmacol., 12, 29–34.
Tuskagoshi S., Hashimoto Y., Fujii Y., Kobayashi H., Nomoto K., Orita K. (1981): Krestin (PSK). Cancer Treat. Rev., 11, 131–155.
Proceedings of the 1993 PSP International Symposium (15–19 November, 1993). Yang Q.Y., Kwok C.Y. (Eds.). China, Fudan University Press.
Vermeulen N.P.E., Bessems J.G.M., Van De Street R. (1992): Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metab. Rev., 24, 367–407.
Yeung J.H.K., Chiu L.C.M., Ooi V.E.C. (1994): Effect of polysaccharide peptide (PSP) on glutathione and protection against paracetamol-induced hepatotoxicity in the rat. Meth. Find Exp. Clin. Pharmacol., 16, 723–729.
Tone Y., Kawamata K., Murakami T., Hagashi Y., Yata N. (1990): Dose-dependent pharmacokinetics and first-pass metabolism of acetaminophen in rats. J. Pharmacobiodyn., 13, 327–335.
Brouwer K.L.R. (1993): Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat. Drug Metab. Dispos., 21, 1129–1133.
Studenberg S.D., Brouwer K.L.R. (1993): Hepatic disposition of acetaminophen and metabolites, pharmacokinetic modelling, protein binding and subcellular distribution. Biochem. Pharmacol., 46, 739–746.
Savina P.M., Brouwer K.L.R. (1992): Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat. Drug Metab. Dispos., 20, 496–501.
Jollow D.J., Thorgeirsson S.S., Potter W.Z., Hashimoto M., Mitchell J.R. (1974): Acetaminophen-induced hepatic necrosis. Pharmacology, 12, 251–271.
Hjelle J.J., Hazelton G.A., Klaassen C.D. (1985): Acetaminophen decreases 3′-phosphate 5′-phosphosulfate and uridine diphosphoglucuronic acid in rat liver. Drug Metab. Dispos., 13, 35–41.
Price V.F., Jollow D.J. (1982): Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther., 220, 504–513.
Kim H.J., Rozman P., Madhu C., Klaassen C.D. (1992): Homeostasis of sulfate and 3′-phosphoadenosine 5′-phosphosulfate in rats after acetaminophen administration. J. Pharmacol. Exp. Ther., 261, 1015–1021.
Levy G., Galinsky R.E., Lin J.H. (1982): Pharmacologic consequences and toxicologic implications of endogenous cosubstrate depletion. Drug Metab. Rev., 13, 1009–1020.
Sweeny D.J., Reinke L.A. (1988): Sulfation of acetaminophen in isolated rat hepatocytes. Relationship to sulfate ion concentration and intracellular levels of 3′-phosphoadenosine-5′-phosphosulfate. Drug Metab. Dispos., 16, 712–715.
Studentberg S.D., Brouwer K.L.R. (1992): Impaired biliary excretion of acetaminophen glucuronide in the isolated perfused rat liver after acute phenobarbital treatment and in vivo phenobarbital pretreatment. J. Pharmacol. Exp. Ther., 261, 1022–1027.
Liu J., Liu Y., Madhu C., Klaassen C.D. (1993): Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice. J. Pharmacol. Exp. Ther., 266, 1607–1613.
Iida S., Mizuma T., Sakuma N., Hayashi M., Awazu S. (1989): Transport of acetaminophen conjugates in isolated rat hepatocytes. Drug Metab. Dispos., 17, 341–344.
Snawder J.E., Benson R.W., Leakey J.E.A., Roberts D.W. (1992): The effect of propylene glycol on the P450-dependent metabolism of acetaminophen and other chemicals in subcellular fractions of mouse liver. Life Sci., 52, 183–189.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yeung, J.H.K., Chiu, L.C.M. & Ooi, V.E.C. Effect of polysaccharide peptide (PSP) on in vivo sulphation and glucuronidation of paracetamol in the rat. European Journal of Drug Metabolism and Pharmacokinetics 20, 287–292 (1995). https://doi.org/10.1007/BF03190246
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190246